Study finds nurse-administered behavioral interventions could help chemotherapy patients manage anticipatory nausea and vomiting

Research published in Cancer Medicine demonstrated that the use of two behavioral interventions, mindfulness relaxation (MR) and relaxing music (RM), helped to reduce incidents of mid-chemotherapy anticipatory nausea and vomiting (ANV) in patients.

Read more

COVID-19 forces transplant programs to reassess their approach to transplant allocation decisions

As the COVID-19 (SARS-CoV-2) pandemic has taken hold in the United States, transplant programs have had to prepare to make critical decisions during a time of severely constrained resources. A transition must be made from the traditional “justice versus utility” approach in organ allocation to a more nuanced allocation scheme based on ethical values that drive decisions in times of absolute scarcity. The goal of this new mind-set is to help guide programs in deciding which patients to transplant, which donors to accept, how to minimize risk and how to ensure the best utilization of transplant team members.

Read more

Baylor Dallas chosen as one of seven U.S. sites for trial of new total artificial heart

About 90 percent of patients with advanced heart failure can be managed by a left ventricular assist device (LVAD). But for the 5 to 10 percent of patients with biventricular failure, an LVAD is not adequate. These patients have no option but a heart transplant or the current version of a total artificial heart.

Read more

When two pandemics collide: providing quality cirrhosis care in the age of COVID

The coronavirus disease 2019 (COVID-19) pandemic has shattered the processes meticulously developed over years by which physicians delivered quality care for patients with cirrhosis. COVID-19 has exposed deep flaws in the structural and process measures developed to follow patients, evaluate disease status and response to therapy, and screen for complications, each of which depends upon frequent physical patient-physician interaction.

Read more